Morphine effects similar to placebo in rheumatoid arthritis

July 27, 2017

(HealthDay)—For patients with chronic fatigue syndrome (CFS)/fibromyalgia (FM) or rheumatoid arthritis (RA), morphine has anti-hyperalgesic effects comparable to placebo, according to a study published online July 19 in PAIN Practice.

Linda Hermans, P.T., from Ghent University in Belgium, and colleagues conducted a randomized, double-blind, placebo-controlled trial. Ten patients with CFS/FM, 11 with RA, and 20 controls were randomized to experimental (10 mg /0.2 mg/mL naloxone) and placebo groups.

The researchers found that at baseline, compared with controls, patients with CFS/FM and RA had lower deep tissue pressure and higher temporal summation. In both patient groups, morphine had a positive effect only on pressure pain thresholds (PPTs); PPTs increased after placebo, but no effects on other pain parameters were objectified. Neither naloxone nor nocebo had significant effects on PPT, deep tissue pain, temporal summation, or conditioned pain modulation (CPM) in the control group.

"The effect of morphine in central sensitization patients appears limited and could have more effect on a peripheral level. Nevertheless, the morphine effect on experimental pain measures was comparable to the of placebo," the authors write. "Naloxone did not significantly affect nociceptive modulation in the healthy participants. These results suggest that temporal summation and conditioned pain modulation are not primarily mediated by opioid mechanisms."

One author disclosed financial ties to the pharmaceutical industry.

Explore further: Can staying active help to prevent chronic pain? Physical activity affects pain modulation in older adults

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Can staying active help to prevent chronic pain? Physical activity affects pain modulation in older adults

February 24, 2017
Older adults with higher levels of physical activity have pain modulation patterns that might help lower their risk of developing chronic pain, reports a study in PAIN, the official publication of the International Association ...

Lumbopelvic stabilization training therapeutic for LBP

January 5, 2017
(HealthDay)—For patients with chronic nonspecific low back pain conditions, lumbopelvic stabilization training (LPST) has a therapeutic effect on pain modulation, according to a study published online Jan. 2 in Pain Practice.

Pregabalin significantly improves neuropathic pain

September 9, 2016
(HealthDay)—Pregabalin significantly improves neuropathic pain, irrespective of the time since pain onset, according to a study published online Sept. 2 in Pain Practice.

Gabapentin doesn't cut use of morphine post-knee arthroplasty

November 27, 2013
(HealthDay)—The addition of gabapentin to patient-controlled analgesia (PCA) protocol does not reduce morphine consumption, pain, or opioid-related side effects in patients undergoing total knee arthroplasty, according ...

New naloxone capsule safe for opioid-induced constipation

July 1, 2015
(HealthDay)—A new naloxone sustained release (NSR) capsule appears to be safe and efficacious for opioid-induced constipation (OIC), according to a study published online June 24 in Pain Medicine.

Study assesses sublingual fentanyl vs morphine for CA pain

January 26, 2017
(HealthDay)—For patients with severe cancer pain episodes, fentanyl sublingual tablets (FST) offer analgesia with modest to moderate increased risk of lower efficacy compared with subcutaneous morphine (SCM), according ...

Recommended for you

New osteoarthritis genes discovered

March 19, 2018
In the largest study of its kind, nine novel genes for osteoarthritis have been discovered by scientists from the Wellcome Sanger Institute and their collaborators. Results of the study, published today (19 March) in Nature ...

Rheumatoid arthritis meets precision medicine

March 19, 2018
Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new Northwestern Medicine multi-site ...

Scientists use nanotechnology to detect molecular biomarker for osteoarthritis

March 12, 2018
For the first time, scientists at Wake Forest Baptist Medical Center have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology.

Biological engineers discover why a promising drug failed in clinical trials

March 7, 2018
Pharmaceutical companies once considered a protein called p38 a very attractive target for treating rheumatoid arthritis. Arthritis patients usually have elevated activity of this inflammation-producing protein, and in lab ...

Scorpion venom component can reduce severity of rheumatoid arthritis

February 26, 2018
A treatment that improves the lives of nearly 1.3 million people with rheumatoid arthritis might one day originate from scorpion venom. A group of researchers led by Dr. Christine Beeton at Baylor College of Medicine has ...

New device for low-cost single-cell analysis identifies fibroblast subtypes in rheumatoid arthritis patients

February 23, 2018
Single-cell analysis holds enormous potential to study how individual cells influence disease and respond to treatment, but the lack of cost-effective and user-friendly instrumentation remains challenging. As described in ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.